Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma
2009 · Journal of Experimental & Clinical Cancer Research · 65 citations
https://doi.org/10.1186/1756-9966-28-116
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
110
Citations
4
h-index
2
i10-index
Ran Aimoto is an academic researcher from Osaka City University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Hematopoietic Stem Cell Transplantation & Acute Lymphoblastic Leukemia research. The author has an h-index of 4, co-authored 7 publications.
Click to start Chat